We are live on ! Find out more
TI

Trexquant Investment Portfolio holdings

AUM $17B
1-Year Est. Return 39.66%
This Fund
S&P 500
This Quarter Est. Return
-5.04%
1 Year Est. Return
+39.66%
3 Year Est. Return
+112.15%
5 Year Est. Return
+98.93%
10 Year Est. Return
+403.68%
AUM
$2.13B
AUM Growth
+$510M
Cap. Flow
+$599M
Cap. Flow %
28.11%
Top 10 Hldgs %
9.95%
Holding
1,881
New
630
Increased
409
Reduced
256
Closed
586

Top Buys

Rank Stock Value
1
MU icon
Micron Technology
MU
+$26.4M
2
JPM icon
JPMorgan Chase
JPM
+$25.9M
3
AMD icon
Advanced Micro Devices
AMD
+$22.6M
4
ADI icon
Analog Devices
ADI
+$20.1M
5
TSLA icon
Tesla
TSLA
+$17.8M

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$20M
2
C icon
Citigroup
C
+$19.9M
3
UBER icon
Uber
UBER
+$17.1M
4
TXN icon
Texas Instruments
TXN
+$17M
5
CMI icon
Cummins
CMI
+$16.3M

Sector Composition

Rank Sector Weight
1 Technology 25.63%
2 Consumer Discretionary 14.93%
3 Healthcare 14.71%
4 Financials 10.85%
5 Industrials 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRSN
1601
DELISTED
Mersana Therapeutics
MRSN
-1,653
Closed -$257K
MRTN icon
1602
Marten Transport
MRTN
$1.14B
-11,297
Closed -$194K
MSBI icon
1603
Midland States Bancorp
MSBI
$683M
-9,443
Closed -$234K
MSFT icon
1604
Microsoft
MSFT
$3.65T
-17,808
Closed -$5.99M
MSM icon
1605
MSC Industrial Direct
MSM
$6.67B
-3,652
Closed -$307K
MTCH icon
1606
Match Group
MTCH
$9.51B
-18,447
Closed -$2.44M
MTUM icon
1607
iShares MSCI USA Momentum Factor ETF
MTUM
$24.9B
-2,449
Closed -$445K
NBIX icon
1608
Neurocrine Biosciences
NBIX
$15.8B
-24,681
Closed -$2.1M
NDAQ icon
1609
Nasdaq
NDAQ
$52.7B
-10,923
Closed -$765K
NDLS icon
1610
Noodles & Co
NDLS
$84.3M
-6,480
Closed -$470K
NDSN icon
1611
Nordson
NDSN
$17.5B
-2,217
Closed -$566K
NEO icon
1612
NeoGenomics
NEO
$2.27B
-18,091
Closed -$617K
NGNE icon
1613
Neurogene
NGNE
$758M
-2,436
Closed -$235K
NMFC icon
1614
New Mountain Finance
NMFC
$690M
-15,148
Closed -$208K
NMRK icon
1615
Newmark Group
NMRK
$2.65B
-53,828
Closed -$1.01M
NTRA icon
1616
Natera
NTRA
$47.6B
-5,449
Closed -$509K
NTRS icon
1617
Northern Trust
NTRS
$33.8B
-7,238
Closed -$866K
NUE icon
1618
Nucor
NUE
$58.5B
-18,305
Closed -$2.09M
NYT icon
1619
New York Times
NYT
$10.7B
-15,261
Closed -$737K
OGN icon
1620
Organon & Co
OGN
$3.59B
-40,081
Closed -$1.22M
ONEQ icon
1621
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.7B
-4,001
Closed -$244K
OPCH icon
1622
Option Care Health
OPCH
$3.54B
-21,275
Closed -$605K
ORMP icon
1623
Oramed Pharmaceuticals
ORMP
$199M
-12,088
Closed -$173K
OSK icon
1624
Oshkosh
OSK
$9.39B
-2,062
Closed -$232K
OSIS icon
1625
OSI Systems
OSIS
$3.15B
-4,683
Closed -$436K

Similar funds

Trexquant Investment's Q1 2022 Portfolio in Review

As of Q1 2022, Trexquant Investment held 1,881 positions worth $2.13B, up 32% from $1.62B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Trexquant Investment deployed $599M of net new capital in Q1 2022, opening 630 new positions and adding to 409 existing holdings. Its largest new stake was JPMorgan Chase: 175,235 shares worth $23.9M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Citigroup, an estimated $19.9M trimmed.

  • Trexquant Investment's largest Q1 2022 buy was JPMorgan Chase: 175,235 shares worth $23.9M.
  • Trexquant Investment added most to Micron Technology in Q1 2022, an estimated $26.4M increase.
  • Trexquant Investment's biggest Q1 2022 reduction was Citigroup, cutting an estimated $19.9M.
  • Trexquant Investment fully exited Chevron in Q1 2022, selling an estimated $20M.
  • Trexquant Investment's ten largest holdings make up 9.9% of its $2.13B portfolio in Q1 2022.
  • Trexquant Investment opened 630 new positions and closed 586 in Q1 2022.
  • Trexquant Investment's portfolio value rose 32% quarter-over-quarter to $2.13B.

Based on Trexquant Investment's 13F filing for Q1 2022, filed 13 May 2022.